← Back to Clinical Trials
Recruiting NCT06950749

NCT06950749 Effects of Robotic Gloves Along With Task-oriented Mirror Therapy on Motor Functions of Hands in Sub-acute Stroke Patients

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06950749
Status Recruiting
Phase
Sponsor Foundation University Islamabad
Condition Stroke
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2024-10-12
Primary Completion 2025-03-15

Eligibility & Interventions

Sex All sexes
Min Age 40 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Robotic Gloves assisted Task-oriented mirror therapyTask-Oriented Mirror Therapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 30 participants in total. It began in 2024-10-12 with a primary completion date of 2025-03-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study is randomized control trial and purpose of this study is to find effects of robotic gloves assisted task-oriented mirror therapy in comparison with task-oriented mirror therapy on motor functions of hand in sub-acute stroke patients.

Eligibility Criteria

Inclusion Criteria: * 40 years and above. * Ischemic (MCA) stroke. * Male and females both. * Montreal Cognitive Assessment (MoCA score \>24 points). * Motor power of proximal upper Extremity at least 3 with ability to reach out. * FMA score for upper Extremity below 47 * Modified Ashworth spasticity score \<2 in hands and finger joints. * Ability to sit for at least 60 minutes Exclusion Criteria: * Musculoskeletal problems such as severe pain in any joints of the paretic upper extremity. * Contractures in shoulder, elbow, hand or finger joints. * Severe Visual impairments.

Contact & Investigator

Central Contact

ABDUL REHMAN, DPT

✉ abdurrehman1730@gmail.com

📞 003037105609

Frequently Asked Questions

Who can join the NCT06950749 clinical trial?

This trial is open to participants of all sexes, aged 40 Years or older, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06950749 currently recruiting?

Yes, NCT06950749 is actively recruiting participants. Contact the research team at abdurrehman1730@gmail.com for enrollment information.

Where is the NCT06950749 trial being conducted?

This trial is being conducted at Islamabad, Pakistan.

Who is sponsoring the NCT06950749 clinical trial?

NCT06950749 is sponsored by Foundation University Islamabad. The trial plans to enroll 30 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology